Open-label, randomized, 2-treament, 2-period, 2-sequence crossover study to compare the pharmacokinetic profile of IP-TA and IP-TB in Japanese healthy volunteers.

2-treament, 2-period, 2-sequence crossover study to compare the pharmacokinetic profile of IP-TA and IP-TB - 2-treament, 2-period, 2-sequence crossover study to compare the pharmacokinetic profile of IP-TA and IP-TB

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000056194

Enrollment

Registered

2024-11-19

Start date

2024-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Administer IP-TA to IP-TB Administer IP-TB to IP-TA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy Japanese volunteer

Exclusion criteria

Exclusion criteria: Any history or presence of clinically relevant disease

Design outcomes

Primary

Measure	Time frame
Cmax of Ibuprofen Partial AUC0-0.5 of Ibuprofen	—

Countries

Japan

Contacts

Public ContactShiho Yamane

SSP Co, Ltd Science Hub, Medical

CHCJPNMed@sanofi.com0363013422

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026